Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Percutaneous vs Intradermal BCG in Infants
NCT00242047Phase 4Unknown
- Sponsor
- University of Cape Town
- Start
- Mar 2001
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bcg vaccine in Tuberculosis (TB) (2 arms), sponsored by University of Cape Town. Primary endpoint: Incidence of Tuberculosis at 2 years. Status: unknown.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00242047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242047.